Detalles de la búsqueda
1.
Debio 1143 and high-dose cisplatin chemoradiotherapy in high-risk locoregionally advanced squamous cell carcinoma of the head and neck: a double-blind, multicentre, randomised, phase 2 study.
Lancet Oncol
; 21(9): 1173-1187, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32758455
2.
Multiple-target chemotherapy (LV-modulated 5-FU bolus and continuous infusion, oxaliplatin, CPT- 11) in advanced 5-FU-refractory colorectal cancer: MTD definition and efficacy evaluation. A phase I-II study.
Tumori
; 92(5): 389-95, 2006.
Artículo
en Inglés
| MEDLINE | ID: mdl-17168430
3.
Debio 0617B Inhibits Growth of STAT3-Driven Solid Tumors through Combined Inhibition of JAK, SRC, and Class III/V Receptor Tyrosine Kinases.
Mol Cancer Ther
; 15(10): 2334-2343, 2016 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-27439479
4.
Analysis of neurosensory adverse events induced by FOLFOX4 treatment in colorectal cancer patients: a comparison between two Asian studies and four Western studies.
Cancer Med
; 1(2): 198-206, 2012 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-23342269
5.
Safety analysis of FOLFOX4 treatment in colorectal cancer patients: a comparison between two Asian studies and four Western studies.
Clin Colorectal Cancer
; 11(2): 127-37, 2012 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-22099928
6.
A phase II study of an oxaliplatin/vinorelbine/5-fluorouracil combination in patients with anthracycline-pretreated and taxane-pretreated metastatic breast cancer.
Anticancer Drugs
; 17(9): 1067-73, 2006 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-17001180
7.
Phase II study of an oxaliplatin/vinorelbine combination in patients with anthracycline- and taxane-pre-treated metastatic breast cancer.
Anticancer Drugs
; 17(3): 337-43, 2006 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-16520663
Resultados
1 -
7
de 7
1
Próxima >
>>